404 related articles for article (PubMed ID: 2121369)
21. Biochemical comparisons of the Saccharomyces cerevisiae Bem2 and Bem3 proteins. Delineation of a limit Cdc42 GTPase-activating protein domain.
Zheng Y; Hart MJ; Shinjo K; Evans T; Bender A; Cerione RA
J Biol Chem; 1993 Nov; 268(33):24629-34. PubMed ID: 8227021
[TBL] [Abstract][Full Text] [Related]
22. Purification and N-terminal sequence of the p21rho GTPase-activating protein, rho GAP.
Garrett MD; Major GN; Totty N; Hall A
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):833-6. PubMed ID: 1905930
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of the putative effector domain of the GTP-binding Ypt1 protein in yeast suggests specific regulation by a novel GAP activity.
Becker J; Tan TJ; Trepte HH; Gallwitz D
EMBO J; 1991 Apr; 10(4):785-92. PubMed ID: 2009858
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of the neurofibromatosis type 1 protein product.
DeClue JE; Cohen BD; Lowy DR
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9914-8. PubMed ID: 1946460
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NF1) gene product, in cell-free systems.
Mori S; Satoh T; Koide H; Nakafuku M; Villafranca E; Kaziro Y
J Biol Chem; 1995 Dec; 270(48):28834-8. PubMed ID: 7499408
[TBL] [Abstract][Full Text] [Related]
26. The C-terminal domains of human neurofibromin and its budding yeast homologs Ira1 and Ira2 regulate the metaphase to anaphase transition.
Luo G; Kim J; Song K
Cell Cycle; 2014; 13(17):2780-9. PubMed ID: 25486365
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of RPI1, a novel inhibitor of the yeast Ras-cyclic AMP pathway, down-regulates normal but not mutationally activated ras function.
Kim JH; Powers S
Mol Cell Biol; 1991 Aug; 11(8):3894-904. PubMed ID: 1649384
[TBL] [Abstract][Full Text] [Related]
28. The kelch proteins Gpb1 and Gpb2 inhibit Ras activity via association with the yeast RasGAP neurofibromin homologs Ira1 and Ira2.
Harashima T; Anderson S; Yates JR; Heitman J
Mol Cell; 2006 Jun; 22(6):819-830. PubMed ID: 16793550
[TBL] [Abstract][Full Text] [Related]
29. The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.
Nur-E-Kamal MS; Varga M; Maruta H
J Biol Chem; 1993 Oct; 268(30):22331-7. PubMed ID: 8226742
[TBL] [Abstract][Full Text] [Related]
30. A yeast GTPase-activating protein that interacts specifically with a member of the Ypt/Rab family.
Strom M; Vollmer P; Tan TJ; Gallwitz D
Nature; 1993 Feb; 361(6414):736-9. PubMed ID: 8441469
[TBL] [Abstract][Full Text] [Related]
31. Primary structure and biochemical characterization of yeast GTPase-activating proteins with substrate preference for the transport GTPase Ypt7p.
Vollmer P; Will E; Scheglmann D; Strom M; Gallwitz D
Eur J Biochem; 1999 Feb; 260(1):284-90. PubMed ID: 10091609
[TBL] [Abstract][Full Text] [Related]
32. The neurofibromatosis type 1 gene encodes a protein related to GAP.
Xu GF; O'Connell P; Viskochil D; Cawthon R; Robertson M; Culver M; Dunn D; Stevens J; Gesteland R; White R
Cell; 1990 Aug; 62(3):599-608. PubMed ID: 2116237
[TBL] [Abstract][Full Text] [Related]
33. Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway.
Buchberg AM; Cleveland LS; Jenkins NA; Copeland NG
Nature; 1990 Sep; 347(6290):291-4. PubMed ID: 2169593
[TBL] [Abstract][Full Text] [Related]
34. Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator.
Martegani E; Vanoni M; Zippel R; Coccetti P; Brambilla R; Ferrari C; Sturani E; Alberghina L
EMBO J; 1992 Jun; 11(6):2151-7. PubMed ID: 1376246
[TBL] [Abstract][Full Text] [Related]
35. A dominant activating mutation in the effector region of RAS abolishes IRA2 sensitivity.
Tanaka K; Wood DR; Lin BK; Khalil M; Tamanoi F; Cannon JF
Mol Cell Biol; 1992 Feb; 12(2):631-7. PubMed ID: 1732735
[TBL] [Abstract][Full Text] [Related]
36. ralGDS family members interact with the effector loop of ras p21.
Kikuchi A; Demo SD; Ye ZH; Chen YW; Williams LT
Mol Cell Biol; 1994 Nov; 14(11):7483-91. PubMed ID: 7935463
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
Marshall MS; Hettich LA
Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
[TBL] [Abstract][Full Text] [Related]
38. Use of yeast two-hybrid system to evaluate Ras interactions with neurofibromin-GTPase-activating protein.
Poullet P; Tamanoi F
Methods Enzymol; 1995; 255():488-97. PubMed ID: 8524136
[No Abstract] [Full Text] [Related]
39. Sst2 is a GTPase-activating protein for Gpa1: purification and characterization of a cognate RGS-Galpha protein pair in yeast.
Apanovitch DM; Slep KC; Sigler PB; Dohlman HG
Biochemistry; 1998 Apr; 37(14):4815-22. PubMed ID: 9537998
[TBL] [Abstract][Full Text] [Related]
40. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
